[HTML][HTML] Tumor quantification in clinical positron emission tomography
Positron emission tomography (PET) is used extensively in clinical oncology for tumor
detection, staging and therapy response assessment. Quantitative measurements of tumor …
detection, staging and therapy response assessment. Quantitative measurements of tumor …
Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours
C Van de Wiele, V Kruse, P Smeets… - European journal of …, 2013 - Springer
Data available in patients suffering from squamous cell carcinoma of the head and neck,
lung carcinoma, oesophageal carcinoma and gynaecological malignancies suggest that …
lung carcinoma, oesophageal carcinoma and gynaecological malignancies suggest that …
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
Purpose We aimed to evaluate if imaging biomarkers on FDG PET are associated with
clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with …
clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with …
EANM/EARL FDG-PET/CT accreditation-summary results from the first 200 accredited imaging systems
Abstract Purpose From 2010 until July 2016, the EANM Research Ltd.(EARL) FDG-PET/CT
accreditation program has collected over 2500 phantom datasets from approximately 200 …
accreditation program has collected over 2500 phantom datasets from approximately 200 …
[HTML][HTML] Radiomic signature of 18F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits
We aimed to evaluate whether radiomic feature-based fluorine 18 (18 F) fluorodeoxyglucose
(FDG) positron emission tomography (PET) imaging signatures allow prediction of gastric …
(FDG) positron emission tomography (PET) imaging signatures allow prediction of gastric …
Feasibility of state of the art PET/CT systems performance harmonisation
A Kaalep, T Sera, S Rijnsdorp, M Yaqub… - European journal of …, 2018 - Springer
Purpose The objective of this study was to explore the feasibility of harmonising
performance for PET/CT systems equipped with time-of-flight (ToF) and resolution …
performance for PET/CT systems equipped with time-of-flight (ToF) and resolution …
Early-Stage Non–Small Cell Lung Cancer: Quantitative Imaging Characteristics of 18F Fluorodeoxyglucose PET/CT Allow Prediction of Distant …
Purpose To identify quantitative imaging biomarkers at fluorine 18 (18F) positron emission
tomography (PET) for predicting distant metastasis in patients with early-stage non–small …
tomography (PET) for predicting distant metastasis in patients with early-stage non–small …
Development of an immune-pathology informed radiomics model for non-small cell lung cancer
With increasing use of immunotherapy agents, pretreatment strategies for identifying
responders and non-responders is useful for appropriate treatment assignment. We …
responders and non-responders is useful for appropriate treatment assignment. We …
18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
Objectives:(1.1) to evaluate the association between baseline 18F-FDG PET/CT semi-
quantitative parameters of the primary lesion with progression free survival (PFS), overall …
quantitative parameters of the primary lesion with progression free survival (PFS), overall …
Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma
Purpose Intratumour uptake heterogeneity in PET quantified in terms of textural features for
response to therapy has been investigated in several studies, including assessment of their …
response to therapy has been investigated in several studies, including assessment of their …